President Donald Trump has said he will sign an executive order today that will cut prescription drug prices supplied to ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

Cambridge, Massachusetts-based Vor Bio has confirmed that it will halt clinical and manufacturing operations, including its ...

The GLISTEN trial of GSK's linerixibat has shown that the oral ileal bile acid transporter (IBAT inhibitor was signposted as ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi ...

Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated ...

Moreover, Downing Street has indicated that the UK will receive "preferential treatment in any further tariffs imposed" as ...

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic ...

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

For instance, studies have shown that approximately 25% of adults with diabetes reported rationing insulin in the previous ...

That is according to the chief executive of the American Association for the Advancement of Science (AAAS), Sudip Parikh, who ...

According to Politico, Trump will issue an executive order in the next few days to pursue the use of a so-called 'most ...